Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06219252 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Intraoperative Aberrometry vs Conventional Intraocular Lens Calculation, a Prospective Study.

Study acronym: ORAVSCTRL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion date: Nov 30, 2024 to Nov 30, 2026
    • Study completion date: Dec 31, 2024 to Dec 31, 2026
    v3
  2. Notable Primary endpoint revisedv2 Show 4 more changesShow less
    • Interventions: Intraoperative aberrometer (Device), Preoperative IOL calculation (Other) to Intraoperative aberrometer (Device), Preoperative intraocular lens calculation (Other)
    • Eligibility criteria revised
    • Study description expanded, about 2 words
    • Study title expanded, about 1 word
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
the goal of this intervention study is to compare prospectively the accuracy of the power calculation between both groups, the intraoperative aberrometry (ORA) vs barrett universal II preoperative calculation (control group) . Researchers will compare ORA group vs control to see changes in spherical equivalent and uncorrected distance visual acuity
Trial Details
NCT Number NCT06219252
Lead Sponsor Instituto de Oftalmología Fundación Conde de Valenciana
Conditions
(from sponsor)
Intraocular Lens Implantation, Cataract, Humans, Ocular, Refraction
Related terms Cataract
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov